arXiv:2605.24912v1 Announce Type: new Abstract: Background: Type 2 diabetes mellitus (T2DM) is increasingly recognised as a systemic disease characterised by coordinated dysfunction across metabolic, renal, lipid, and inflammatory pathways. Existing clinical assessments often fail to capture this multi-dimensional burden. Methods: We conducted a retrospective study of 1,195 patients using routinely collected laboratory biomarkers. System-level abnormality indices were constructed to quantify organ-specific dysfunction, and multi-system involvement was defined as abnormalities in two or more sy
The convergence of advanced AI with accessible medical imaging, particularly retinal scans, makes this development possible now.
This research demonstrates a non-invasive, scalable method to predict multi-organ dysfunction in Type 2 Diabetes, potentially revolutionizing early diagnosis and personalized treatment pathways.
Clinical assessments for Type 2 Diabetes could integrate AI-powered retinal imaging to provide a more comprehensive and early view of systemic health, shifting from reactive to proactive care.
- · Diabetic patients
- · Healthcare providers
- · AI in healthcare companies
- · Medical imaging manufacturers
- · Legacy diagnostic methods
- · Healthcare systems slow to adopt AI
Earlier intervention for multi-organ complications in diabetes patients.
Reduced healthcare costs associated with managing advanced diabetic complications.
Personalized medicine approaches for chronic diseases become more widespread due to AI-driven predictive analytics.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG